Summary: Donation of CCP, Blood Components and HCT/Ps Following COVID-19 Vaccines or Treatment with CCP or Monoclonals (updated 02/12/21)
This section contains information on questionnaires used to screen prospective donors and help ensure the safety of the donation process as well as the product being donated. AABB has played a leadership role in the development of model questionnaires for blood collection facilities as well as for facilities involved in the collection of hematopoietic progenitor cells (HPCs).
Schiff, Maloney Introduce Resolution Highlighting the Need for Equitable Blood Donation Policies
April 06, 2021
OneBlood Officials Describe Development of CCP Program in New Research Article
March 02, 2021
February 09, 2021